151 related articles for article (PubMed ID: 8927037)
1. In vivo effects of peroxovanadium compounds in BB rats.
Yale JF; Vigeant C; Nardolillo C; Chu Q; Yu JZ; Shaver A; Posner BI
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):181-90. PubMed ID: 8927037
[TBL] [Abstract][Full Text] [Related]
2. Hypoglycemic effects of peroxovanadium compounds in Sprague-Dawley and diabetic BB rats.
Yale JF; Lachance D; Bevan AP; Vigeant C; Shaver A; Posner BI
Diabetes; 1995 Nov; 44(11):1274-9. PubMed ID: 7589823
[TBL] [Abstract][Full Text] [Related]
3. Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics.
Posner BI; Faure R; Burgess JW; Bevan AP; Lachance D; Zhang-Sun G; Fantus IG; Ng JB; Hall DA; Lum BS
J Biol Chem; 1994 Feb; 269(6):4596-604. PubMed ID: 8308031
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
Yuen VG; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
[TBL] [Abstract][Full Text] [Related]
5. [Hypoglycemic effects of bis(maltolato)oxovanadium administered by different routes upon diabetic rats].
Zhong XY; Zhang H; Zhang X; Lv WL; Zhang Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 36(3):313-8. PubMed ID: 15205708
[TBL] [Abstract][Full Text] [Related]
6. Vanadium compounds as insulin mimics.
Orvig C; Thompson KH; Battell M; McNeill JH
Met Ions Biol Syst; 1995; 31():575-94. PubMed ID: 8564818
[TBL] [Abstract][Full Text] [Related]
7. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.
Li M; Ding W; Smee JJ; Baruah B; Willsky GR; Crans DC
Biometals; 2009 Dec; 22(6):895-905. PubMed ID: 19404749
[TBL] [Abstract][Full Text] [Related]
8. The effects of vanadium treatment on bone in diabetic and non-diabetic rats.
Facchini DM; Yuen VG; Battell ML; McNeill JH; Grynpas MD
Bone; 2006 Mar; 38(3):368-77. PubMed ID: 16256449
[TBL] [Abstract][Full Text] [Related]
9. Administration of optimum sustained-insulin release PLGA microcapsules to spontaneous diabetes-prone BB/Wor//Tky rats.
Takenaga M; Yamaguchi Y; Ogawa Y; Kitagawa A; Kawai S; Mizushima Y; Igarashi R; Namae M; Komeda K
Drug Deliv; 2006; 13(2):149-57. PubMed ID: 16423804
[TBL] [Abstract][Full Text] [Related]
10. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 activity exerts an antidiabetic action in Goto-Kakizaki rats.
Abella A; Marti L; Camps M; Claret M; Fernández-Alvarez J; Gomis R; Gumà A; Viguerie N; Carpéné C; Palacín M; Testar X; Zorzano A
Diabetes; 2003 Apr; 52(4):1004-13. PubMed ID: 12663473
[TBL] [Abstract][Full Text] [Related]
11. The anti-diabetic effects and pharmacokinetic profiles of bis(maltolato)oxovanadium in non-diabetic and diabetic rats.
Zhang SQ; Zhong XY; Chen GH; Lu WL; Zhang Q
J Pharm Pharmacol; 2008 Jan; 60(1):99-105. PubMed ID: 18088510
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of various vanadium salts on glucose homeostasis in streptozotocin-diabetic rats.
Becker DJ; Ongemba LN; Henquin JC
Eur J Pharmacol; 1994 Aug; 260(2-3):169-75. PubMed ID: 7988641
[TBL] [Abstract][Full Text] [Related]
13. Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats.
Meyerovitch J; Backer JM; Kahn CR
J Clin Invest; 1989 Sep; 84(3):976-83. PubMed ID: 2547842
[TBL] [Abstract][Full Text] [Related]
14. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
Reul BA; Amin SS; Buchet JP; Ongemba LN; Crans DC; Brichard SM
Br J Pharmacol; 1999 Jan; 126(2):467-77. PubMed ID: 10077240
[TBL] [Abstract][Full Text] [Related]
15. Transdermally delivered peroxovanadium can lower blood glucose levels in diabetic rats.
Brand RM; Hamel FG
Int J Pharm; 1999 Jun; 183(2):117-23. PubMed ID: 10361162
[TBL] [Abstract][Full Text] [Related]
16. The protein tyrosine phosphatase inhibitor, pervanadate, is a powerful antidiabetic agent in streptozotocin-treated diabetic rats.
Shisheva A; Ikonomov O; Shechter Y
Endocrinology; 1994 Jan; 134(1):507-10. PubMed ID: 8275968
[TBL] [Abstract][Full Text] [Related]
17. Short-term bioaccumulation of vanadium when ingested with a tea decoction in streptozotocin-induced diabetic rats.
Edel AL; Kopilas M; Clark TA; Aguilar F; Ganguly PK; Heyliger CE; Pierce GN
Metabolism; 2006 Feb; 55(2):263-70. PubMed ID: 16423636
[TBL] [Abstract][Full Text] [Related]
18. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
[TBL] [Abstract][Full Text] [Related]
19. Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis.
Bevan AP; Drake PG; Yale JF; Shaver A; Posner BI
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):49-58. PubMed ID: 8927047
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal study of first phase insulin release in the BB rat.
Reddy S; Bibby NJ; Fisher SL; Elliott RB
Diabetologia; 1986 Nov; 29(11):802-7. PubMed ID: 3545956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
